Profile History

   
History

Date

Description

  2010-10-12 2010 Taipei International Symposium on Human Cell and Tissue-based Products and Tissue Banks was host by Food and Drug Administration, Department of Health, Executive Yuan(TFDA) and held by EMO Biomedicine Corp.  

  2009-11-24 In 2008, Food and Drug Administration, Department of Health, Executive Yuan, Taiwan (TFDA) published the “Regulation Guidance of Laboratory on Quality Control of Testing Results” to ensure technical competence and quality of analysis data of testing laboratory.
The research and development of EMO Biomedicine Corp (EMO) obtained the certificate of accreditation as a qualified “Drugs and Cosmetics Testing Laboratory” from TFDA in November 2009. The accreditation is in accordance with ISO/IEC 17011 and ISO/IEC 19011 as well as National Standard of Republic of China (CNS 17025 Z4058).
 

  2009-01-21

Accroding to the Joint IAF-ILAC-ISO communique announced at Jan. 2009 A laboratorys fulfilment of the requirement of ISO/IEC 17025-2005 means the management system of the lab meets the principles of ISO 9001:2008 Quality Management System- Requirment.

 

2008-10-15
Oct. 01~03 2008, EMO Biomedicine Corp. held “The 3rd Annual Taipei International Symposium on Human Cell and Tissue-based Products” at National Taiwan University Hospital International Convention Center. Speakers had shared their experience and activities of the forum.
 

  2008-09-30
Sep. 10 2008, The R&D department of EMO Biomedicine Corp. has obtained an extensive accreditation from TAF. With the foundation of “Offering a more complete service for customers”, EMO Biomedicine Corp. has been extending the scope of accreditation. “Cell Proliferation /Cytotoxicity Assay” has been through two extensive accreditation on 28 Nov. 2007 and 10 Sep. 2008, respectively. With TAF’s accreditation, the accredited cell lines have been increased from 6 cell lines all the way to 14 cell lines. Furthermore, EMO Biomedicine Corp. has obtained 3 additional assays, “NK Cell Cytotoxicity Assay”, “Protein Expression Assay” and “Mycoplasma Assay”, to provide a broader selection platform for our customers.

  2008-07-24

EMO presented our cell-based Biological Response related reserch and detection items on the exhibit "BIO Taiwan 2008".

 

  2007-11-28
The R&D department of EMO Biomedicine obtained the Certificate of Accreditation by Taiwan Accreditation Foundation (TAF) again for the expansion on its’ laboratory testing items. The newly accredited items include “analysis of anti-tumor activity” and “NK cell phenotyping”
 

  2007-10-04
“The Trend of Cell and Gene Therapy” conference was hosted by Bureau of Food and Drug Analysis (BFDA) and co-organized by EMO Biomedicine Corp. in Taipei, on Oct 4th, 2007 (keynote speakers: Dr. Darin J. Weber, Dr. Scott R. Burger, and Dr. Madhusudan V. Peshwa).

  2007-10-02
“2007 International Symposium on Regulation of Human Cell and Tissue-Based Products” was held from Oct 2nd to 3rd, 2007 in Taipei, The conference was organized by Bureau of Food and Drug Analysis (BFDA) Department of Health, Industrial Technology Research Institute (ITRI), and EMO Biomedicine Corp.
 

2007-06-20
The R&D department of EMO Biomedicine Corp. obtained the Certificate of Accreditation by Taiwan Accreditation Foundation (TAF) as an accredited Testing Laboratory.
 

2006-03-22
Dr. Joe Zendegui, VP of Corporate Development of Canadian biotech company, Chromos Molecular Systems, signed an intent cooperation agreement with Mr. Lee, CEO of EMO Biomedicine Corp., in Taipei on March 22nd, 2006. 。
 

2005-12-02
EMO Biomedicine Corp. in Taipei announced intent to form a cell therapy joint venture with Chromos Molecular Systems of Canada to treat Chronic Hepatitis B with antigen-specific CTL.
 

2004-05
Completed the construction of clean room (ISO 7 & ISO 8 class) and analytical Laboratory for Human Cell-based Products.
 

2004-02
EMO Biomedicine Corp. was established.